Multifocal Intraocular Lens x Monovision x Hybrid Monovision After Bilateral Cataract Surgery
Cataract, Presbyopia
About this trial
This is an interventional treatment trial for Cataract focused on measuring multifocal IOL, monovision, hybrid monovision, spectacles independence
Eligibility Criteria
Inclusion Criteria:
- Bilateral senile cataracts.
- Implantation of IOL in the capsular bag;
- Implants from 10-30 diopter;
- Potential Visual Acuity in ≥ 0.2 logMAR (20/32, metric scale) after surgery;
Exclusion Criteria:
- Amblyopia;
- Single Eye;
- History of intraocular surgery in the previous year;
- Sequel to prior ocular trauma;
- Important Microphthalmia or aniridia;
- History of damage to the corneal endothelium (chemical burns, herpetic keratitis, corneal guttata);
- Corneal astigmatism > 1.0 D;
- IOP ≥ 21 mmHg in standard caliper;
- Ocular pathology that affects visual function (uveitis, diabetic retinopathy, age-related macular degeneration, macular dystrophy, retinal detachment, glaucoma, optic neuropathy);
- Pupil > 5 mm or < 2 mm under photopic conditions;
- Asymmetrical pupils in the eye or between the eyes;
- Binocular vision absence;
- Any situation that endangers the implant position in the capsular bag (post-traumatic zonular weakness, pseudoexfoliation, for example);
- Patient probably need to laser treatment of the retina;
- Patients whose expectations are unrealistic;
- Patients whose lifestyle involves high expectations of visual acuity (writer, driver, for example);
- Patients at risk of not meeting the clinical follow-up requirements (distance of travel difficulties, for example);
Sites / Locations
- Department of Ophthalmology and Visual Sciences from the Federal University of Sao Paulo (UNIFESP)
Arms of the Study
Arm 1
Arm 2
Arm 3
Experimental
Experimental
Experimental
Multifocal IOL
Monovision
Hybrid Monovision
Cataract removal with topical anesthesia and phacoemulsification is performed. At the end, multifocal intraocular lens implantation in both eyes planning for emmetropia complete the intervention.
Cataract removal with topical anesthesia and phacoemulsification is performed. At the end, a monofocal intraocular lens implantation planning for emmetropia in one eye (dominant) and a monofocal IOL planning for 1.50 D of myopia in the other eye (non-dominant) complete the intervention.
Cataract removal with topical anesthesia and phacoemulsification is performed. At the end, a monofocal intraocular lens implantation in the dominant eye and a multifocal IOL in the non-dominant eye complete the intervention.